Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. Revenue 2016–2025
Rhythm Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rhythm Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 60.1 M, a 83.81% increase year-over-year.
- Rhythm Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 192.6 M, a 73.84% increase year-over-year.
- Rhythm Pharmaceuticals Inc. annual revenue for 2025 was 189.8 M, a 45.83% increase from 2024.
- Rhythm Pharmaceuticals Inc. annual revenue for 2024 was 130.1 M, a 68.06% increase from 2023.
- Rhythm Pharmaceuticals Inc. annual revenue for 2023 was 77.4 M, a 227.56% increase from 2022.
- Rhythm Pharmaceuticals Inc. annual revenue for 2022 was 23.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rhythm Pharmaceuticals Inc. Market Cap — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RYTM's market cap history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.